SCHEMBL4769353

SCHEMBL4769353

COc1cccc(C)c1C1CC1C(=O)Nc1sc2c(c1C#N)CCNC2

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.50
NPC1 O15118 3/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ALDH1A1 P00352 4/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 1/20 0.42
RECQL P46063 1/20 0.42
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 2/20 0.40
TGFBR1 P36897 2/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775272 0.92 POLB (0.43) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4766464 0.88 POLB (0.48) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL2894804 0.87 NPC1 (0.49) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4766038 0.87 POLB (0.48) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4771906 0.87 POLB (0.44) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4767800 0.86 POLB (0.47) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4963439 0.84 ALDH1A1 (0.43) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4963443 0.84 ALDH1A1 (0.44) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4776053 0.83 ALDH1A1 (0.44) POLBNPC1MEN1KMT2AALDH1A1
SCHEMBL4775000 0.83 ALDH1A1 (0.45) POLBNPC1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed